KC

Kleem Chaudhary

President & Chief Executive Officer

Hyku Biosciences

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Hyku Biosciences
Industry
research
Employees
21.0
Seniority
C suite

Technologies

Outlook Microsoft Office 365 Squarespace ECommerce Adobe Media Optimizer Google Font API Google Maps Mobile Friendly Vimeo Cedexis Radar Typekit DoubleClick Google AdSense Apache KNIME AI

Keywords

biotechnology research drug discovery covalent targeting disease-causing proteins small molecule therapeutics precision medicine novel mechanisms of action therapeutic development covalent medicines histidine targeting tyrosine targeting lysine targeting chemoproteomics druggable proteome binding pockets rational drug design compound library therapeutic benefits selectivity druggability resistance clinical development biopharmaceutical industry proteomics medicinal chemistry therapeutic candidates first-in-class medicines best-in-class medicines integrated platform machine learning computational chemistry chemistry innovation proteomic screening live cell screening context-based chemoproteomics target selection unmet clinical needs burlington ma biotechnology pharmaceutical pipeline programs chemistry research pharmacology therapeutic strategies drug modulation covalent inhibitors drug design challenges biotech investment executive leadership scientific collaboration clinical strategy artificial intelligence information technology & services medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans